0000899243-18-025393.txt : 20180926 0000899243-18-025393.hdr.sgml : 20180926 20180926214038 ACCESSION NUMBER: 0000899243-18-025393 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180924 FILED AS OF DATE: 20180926 DATE AS OF CHANGE: 20180926 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Castelein Caley CENTRAL INDEX KEY: 0001355758 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38560 FILM NUMBER: 181089327 MAIL ADDRESS: STREET 1: THOM. WEISEL HEALTHCARE VENTURES STREET 2: ONE MONTGOMERY STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aerpio Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001422142 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611547850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 BUSINESS PHONE: (513) 985-1920 MAIL ADDRESS: STREET 1: 9987 CARVER ROAD CITY: CINCINNATI STATE: OH ZIP: 45242 FORMER COMPANY: FORMER CONFORMED NAME: ZETA ACQUISITION CORP II DATE OF NAME CHANGE: 20071227 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-24 0 0001422142 Aerpio Pharmaceuticals, Inc. ARPO 0001355758 Castelein Caley ONE EMBARCADERO, SUITE 3700 SAN FRANCISCO CA 94111 1 0 0 0 Common Stock 2018-09-24 4 J 0 268987 0.00 A 279907 D Common Stock 2018-09-24 4 D 0 1603526 0.00 D 0 I See Footnote These shares were received pursuant to a distribution made by Kearny Venture Associates III, LLC in connection with the entity's liquidation. Consists of (i) 1,571,475 shares of Common Stock owned directly by Kearny Venture Partners, L.P., or KVP, and (ii) 32,051 shares of Common Stock owned directly by Kearny Venture Partners Entrepreneurs Fund, L.P., or KVPE. The general partner of both KVP and KVPE is Kearny Venture Associates, L.L.C., or KVA. KVA has the sole voting and investment control over the shares owned by KVP and KVPE, and the Managing Members of KVA share in the voting and investment control over such shares controlled by KVA. The Managing Members of KVA are Caley Castelein, Richard Spalding and James Shapiro. None of the Managing Members of KVA has individual voting or investment power with respect to such shares and each disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. These shares were distributed to third parties pursuant to a distribution made by the entities in connection with their liquidation. /s/ Caley Castelein 2018-09-25